Journal of Antivirals & Antiretrovirals : Citations & Metrics Report
Articles published in Journal of Antivirals & Antiretrovirals have been cited by esteemed scholars and scientists all around the world. Journal of Antivirals & Antiretrovirals has got h-index 22, which means every article in Journal of Antivirals & Antiretrovirals has got 22 average citations.
Following are the list of articles that have cited the articles published in Journal of Antivirals & Antiretrovirals.
2022 | 2021 | 2020 | 2019 | 2018 | |
---|---|---|---|---|---|
Year wise published articles |
32 | 59 | 77 | 13 | 11 |
Year wise citations received |
172 | 256 | 226 | 169 | 197 |
Journal total citations count | 1776 |
Journal impact factor | 5.32 |
Journal 5 years impact factor | 5.62 |
Journal cite score | 5.3 |
Journal h-index | 22 |
Journal h-index since 2018 | 17 |
Important citations (1101)
Unlocking the health potential of microalgae as sustainable sources of bioactive compounds |
|
The potential of algal biotechnology to produce antiviral compounds and biopharmaceuticals |
|
Strategies to obtain designer polymers based on cyanobacterial extracellular polymeric substances (eps) |
|
Protective effect of 3-bromo-4,5-dihydroxybenzaldehyde from polysiphonia morrowii harvey against hydrogen peroxide-induced oxidative stress in vitro and in vivo |
|
Chapter eleven - algal and microbial exopolysaccharides: new insights as biosurfactants and bioemulsifiers |
|
Marine algal carbohydrates as carbon sources for the production of biochemicals and biomaterials |
|
Influence of sulphate on the composition and antibacterial and antiviral properties of the exopolysaccharide from porphyridium cruentum |
|
Performance characteristics of finger-stick dried blood spots (dbs) on the determination of human immunodeficiency virus (hiv) treatment failure in a pediatric population in mozambique |
|
Uptake of routine viral load testing among people living with hiv and its implementation challenges in yangon region of myanmar: a mixedmethods study |
|
The performance of a new point-of-care hiv virus load technology to identify patients failing antiretroviral treatment |
|
Immunoinformatics and molecular modeling approach to design universal multi-epitope vaccine for sars-cov-2 |
|
Subtractive proteomics to identify targets for vaccine development against vancomycin-resistant enterococcus faecalis |
|
Identification of therapeutic drug target of stenotrophomonas maltophilia through subtractive genomic approach and in-silico screening based on 2d similarity filtration and molecular dynamic simulation |
|
Subtractive genomic analysis for identification of novel drug targets and vaccine candidates against bartonella bacilliformis subsp. ver097 |
|
Emerging antibiotic resistance in mycoplasma microorganisms, designing effective and novel drugs / therapeutic targets: current knowledge and futuristic prospects |
|
An immunopharmacoinformatics approach in development of vaccine and drug candidates for west nile virus |
|
Emerging antibiotic resistance in mycoplasma microorganisms, designing effective and novel drugs / therapeutic targets: current knowledge and futuristic prospects |
|
Potential drug target identification of legionella pneumophila by subtractive genome analysis: an in silico approach |
|
Prevalence of intestinal parasitic protozoan infections among female hiv/aids patients attending aminu kano teaching hospital, kano, kano state, nigeria |
|
Modeling novel putative drugs and vaccine candidates against tick-borne pathogens: a subtractive proteomics approach |
|